
Lavipharm S.A.
LAVI | AT
Overview
Corporate Details
- ISIN(s):
- GRS246003008
- LEI:
- 213800USC69CRPRGWJ15
- Country:
- Greece
- Address:
- AGIAS MARINAS STR, 19002 PAIANIA
- Website:
- https://lavipharm.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Established in 1911, Lavipharm is today an integrated group of companies engaged in the research, development, manufacturing, import, marketing and sales, wholesaling and 3PL of pharmaceutical, dermocosmetic and healthcare products in Greece, with a strong international activity. Our key features: ▪ Strong global player in pharmaceutical technologies with expertise on transdermal drug delivery systems ▪ Focus on international expansion ▪ Partner of choice for major international pharmaceutical and consumer health companies in Greece and abroad ▪ An innovator in specialty pharmacy services establishing a dynamic network across Greece ▪ Well-positioned for short, medium and long term growth
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-11 16:30 |
General Meeting Notice
ΠΡΟΣΚΛΗΣΗ ΣΕ ΤΑΚΤΙΚΗ ΓΕΝΙΚΗ ΣΥΝΕΛΕΥΣΗ
|
Greek (modern) | 191.0 KB | |
2025-05-15 16:19 |
Earnings Release
Βασικά Οικονομικά Μεγέθη A Τριμήνου 2025
|
Greek (modern) | 118.2 KB | |
2025-05-15 16:19 |
Earnings Release
Financial Results Q1 2025
|
English | 92.6 KB | |
2025-04-24 16:39 |
Company Presentation
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
English | 1.0 MB | |
2025-04-24 16:39 |
Investor Presentation
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
Greek (modern) | 116.5 KB | |
2025-04-24 16:39 |
Investor Presentation
Annual Analists Briefing
|
English | 61.4 KB | |
2025-04-24 16:39 |
Investor Presentation
Annual Analists Briefing
|
English | 1.0 MB | |
2025-04-14 16:55 |
Regulatory News Service
ΔΕΛΤΙΟ ΤΥΠΟΥ
|
Greek (modern) | 206.9 KB | |
2025-04-03 20:34 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2024,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 2.9 MB | |
2025-04-03 20:34 |
Annual Report (ESEF)
Financial Report LAVIPHARM S.A. (2024,Year Statement,Both)-iXBRL
|
English | 2.1 MB | |
2024-03-21 18:55 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2023,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 3.6 MB | |
2023-03-27 19:46 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2022,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 1.8 MB | |
2022-03-21 18:15 |
Annual Report (ESEF)
Οικονομική Έκθεση LAVIPHARM Α.Ε. (2021,Ετήσιος Ισολογισμός,Μητρική-Ενοποιημένη)…
|
Greek (modern) | 4.4 MB | |
2015-10-01 00:00 |
Annual Report
Financial Statement and Information LAVIPHARM S.A. (2007,Year Statement,Both)
|
English | 118.5 KB | |
2015-09-28 00:00 |
Interim Report
Financial Statement - Full Notes LAVIPHARM S.A. (2007,Six-Month Statement,Compa…
|
English | 143.5 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
Ananda Pharma Plc | United Kingdom | N/A | ||
![]() |
Antibiotice S.A. | Romania | ATB |